The experiment that started in Wuhan and soon started in Canada also received positive results and showed that it is safe and effective in creating an immune response • "Side effects were moderate"

• Illustration

  Photo: 

  Islands. times

An early trial for a potential corona vaccine has yielded promising results. The experiment that began in Wuhan, China and will soon begin in Canada, also received positive results and showed that it is safe and effective in producing an immune response.

Yesterday's study showed that CanSino Biologics Inc.'s vaccine compound needs further trials to determine to what extent it actually protects against SARS-CoV-2, the virus that causes Corona.

Facts about the Corona virus // Photo: Madra spokesmen

However, early trials involving 108 adults in Wuhan showed that vaccine-induced antibodies developed after 28 days, and a response was made to T cells that form part of the immune system. The common side effects among the trial participants were relatively mild and included injection site pain, fever, fatigue and headaches.

As mentioned earlier, the University of Dalhousie in Canada will begin another clinical trial on vaccination in the coming weeks. University researchers said the first clinical trial for a potential vaccine would start with less than a hundred people aged 18 to 55. Then expand to nearly 500 people across Canada, including 65 to 85.

A Beijing professor in charge of research emphasizes that the findings should be interpreted with caution, but says the vaccine appears to be quite promising. "We're still a long way from when the vaccine will be available to everyone," said Wei Chen of the Beijing Biotechnology Institute.

More on:

Success in experimenting on humans in Corona vaccine

Will there be a vaccine for Corona by September?

Trump has announced a huge vaccine development project for Corona

The study members note several limitations of the experiment, including the small sample size, relatively short duration, and the absence of a randomized control group. However, the second phase of the experiment has already begun in Wuhan, and significant research progress is expected.

A few days ago, it was reported that the first vaccine against the corona virus that has reached the clinical trials stage in humans has also emerged as safe and beneficial so far - according to the US-developed vaccine company, "Modern", according to preliminary results of the trials.